Brief: Simcere Pharmaceutical Says Hypnotics Daridorexant Hydrochloride Tablets Got Certificate Of Drug/Product Registration
22/05/2024 15:57
May 22 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* HYPNOTICS DARIDOREXANT HYDROCHLORIDE TABLETS GOT
CERTIFICATE OF
DRUG/PRODUCT REGISTRATION
* CERTIFICATE OF DRUG/ PRODUCT REGISTRATION FOR TABLETS
ISSUED BY
PHARMACY AND POISONS BOARD OF HONG KONG
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660